Literature DB >> 9864084

Case report: possible neuroleptic malignant syndrome associated with olanzapine.

D A Moltz, R R Coeytaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9864084     DOI： 10.1097/00004714-199812000-00014

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Olanzapine: an updated review of its use in the management of schizophrenia.

Authors:  N Bhana; R H Foster; R Olney; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

Authors:  Julian N Trollor; Xiaohua Chen; Perminder S Sachdev
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome?

Authors:  Vassilis P Kontaxakis; Beata J Havaki-Kontaxaki; Nikolaos G Christodoulou; Konstantinos G Paplos; George N Christodoulou
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-10-29

5.  Forced Diuresis and Expedient Blood Pressure Control in the Management of Quetiapine Induced Neuroleptic Malignant Syndrome: A Case Report.

Authors:  Neville Aquilina; Vincent Bugeja
Journal:  Open Access Maced J Med Sci       Date:  2018-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.